- Home
- XERS vs SHLS Comparison
XERS vs SHLS Comparison
Compare XERS & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- SHLS
- Stock Information
- Founded
- XERS 2005
- SHLS 1996
- Country
- XERS United States
- SHLS United States
- Employees
- XERS N/A
- SHLS N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- SHLS Semiconductors
- Sector
- XERS Health Care
- SHLS Technology
- Exchange
- XERS Nasdaq
- SHLS Nasdaq
- Market Cap
- XERS 1.3B
- SHLS 1.1B
- IPO Year
- XERS 2018
- SHLS 2021
- Fundamental
- Price
- XERS $8.33
- SHLS $8.53
- Analyst Decision
- XERS Strong Buy
- SHLS Buy
- Analyst Count
- XERS 7
- SHLS 20
- Target Price
- XERS $8.00
- SHLS $9.74
- AVG Volume (30 Days)
- XERS 2.1M
- SHLS 5.2M
- Earning Date
- XERS 11-07-2025
- SHLS 11-04-2025
- Dividend Yield
- XERS N/A
- SHLS N/A
- EPS Growth
- XERS N/A
- SHLS N/A
- EPS
- XERS N/A
- SHLS 0.12
- Revenue
- XERS $246,025,000.00
- SHLS $400,354,000.00
- Revenue This Year
- XERS $43.89
- SHLS $18.14
- Revenue Next Year
- XERS $20.40
- SHLS $14.50
- P/E Ratio
- XERS N/A
- SHLS $71.49
- Revenue Growth
- XERS 35.62
- SHLS N/A
- 52 Week Low
- XERS $2.73
- SHLS $2.71
- 52 Week High
- XERS $8.51
- SHLS $9.22
- Technical
- Relative Strength Index (RSI)
- XERS 61.63
- SHLS 65.98
- Support Level
- XERS $7.88
- SHLS $7.31
- Resistance Level
- XERS $8.51
- SHLS $9.22
- Average True Range (ATR)
- XERS 0.37
- SHLS 0.55
- MACD
- XERS -0.01
- SHLS 0.08
- Stochastic Oscillator
- XERS 83.05
- SHLS 71.85
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.